Page last updated: 2024-10-24

busulfan and Lymphoma, T Cell, Peripheral

busulfan has been researched along with Lymphoma, T Cell, Peripheral in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jacobsen, ED1
Kim, HT1
Jeter, E1
Jacobson, C1
Fisher, DC1
Armand, P1
Zain, J1
Palmer, JM1
Delioukina, M1
Thomas, S1
Tsai, NC1
Nademanee, A1
Popplewell, L1
Gaal, K1
Senitzer, D1
Kogut, N1
O'Donnell, M1
Forman, SJ1
Ahn, JS1
Yang, DH1
Jung, SH1
Chae, YS1
Sohn, SK1
Yhim, HY1
Kwak, JY1
Lee, SR1
Kim, YK1
Kim, HJ1
Lee, JJ1

Other Studies

3 other studies available for busulfan and Lymphoma, T Cell, Peripheral

ArticleYear
Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma.
    Bone marrow transplantation, 2022, Volume: 57, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Gemcitabine; Hematopoietic Stem Cell Trans

2022
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosp

2011
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
    Annals of hematology, 2013, Volume: 92, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Thera

2013
chemdatabank.com